Serum amyloid A, in vivo splenic cholesterol export and its potential implications in hemolytic disorders

References

• Anders R F, Natvig J B, Michaelsen T E, Husby G. Isolation and characterization of amyloid related serum protein SAA as a low molecular weight protein. Scand J Immunol 1975; 4: 397–401
   PubMedGoogle Scholar
• Benson M D, Skinner M, Lian J, Cohen A S. A protein of amyloidosis: isolation of a cross-reaction component from serum by affinity chomatography. Arthitis Rheum 1975; 18: 315–322
   PubMedGoogle Scholar
• Isersky C, Page D L, Cuatrecasas P, DeLillis R A, Glenner G G. Murine amyloidosis: immunologic characterization of amyloid fibril protein. J Immunol 1971; 107: 1690–1698
   PubMedGoogle Scholar
• Husby G, Natvig J B. A serum component related to nonimmunoglobulin amyloid protein AS, a possible precursor of the fibrils. J Clin Invest 1974; 53: 1054–1061
   PubMed Web of Science ®Google Scholar
• Uhlar C M, Burgess C J, Sharp P M, Whitehead A S. Evolution of the serum amyloid A (SAA) protein superfamily. Genomics 1994; 19: 228–235
   PubMed Web of Science ®Google Scholar
• Santiago P, Roig-Lopez J L, Santiago C, Garcia-Arraras J E. Serum amyloid A protein in an echinoderm: its primary structure and expression during intestinal regeneration in the sea cucumber. Holothuria glaberrima J Exp Zool 2000; 288: 335–344
   PubMedGoogle Scholar
• Manley P N, Ancsin J B, Kisilevsky R. Rapid recycling of cholesterol: the joint biologic role of C-reactive protein and serum amyloid A. Med Hypotheses 2006; 66: 784–792
   PubMed Web of Science ®Google Scholar
• Kisilevsky R, Tam S P. Acute phase serum amyloid A, cholesterol metabolism, and cardiovascular disease. Pediatr Pathol Mol Med 2002; 21: 291–305
   PubMedGoogle Scholar
• Banka C L, Yuan T, De Beer M C, Kindy M, Curtiss L K, de Beer F C. Serum amyloid A (SAA): influence on HDL-mediated cellular cholesterol efflux. J Lipid Res 1995; 36: 1058–1065
   PubMed Web of Science ®Google Scholar
• Ely S, Bonatesta R, Ancsin J B, Kindy M, Kisilevsky R. The in-vitro influence of serum amyloid A isoforms on enzymes that regulate the balance between esterified and un-esterified cholesterol. Amyloid J Prot Folding Disord 2001; 8: 169–181
   PubMed Web of Science ®Google Scholar
• Tam S P, Flexman A, Hulme J, Kisilevsky R. Promoting export of macrophage cholesterol: the physiological role of a major acute-phase protein, serum amyloid A 2.1. J Lipid Res 2002; 43: 1410–1420
   PubMed Web of Science ®Google Scholar
• Kisilevsky R, Tam S P. Macrophage cholesterol efflux and the active domains of serum amyloid A2.1. J Lipid Res 2003; 44: 2257–2269
   PubMed Web of Science ®Google Scholar
• Tam S P, Ancsin J B, Tan R, Kisilevsky R. Peptides derived from serum amyloid A prevent, and reverse, aortic lipid lesions in apoE−/− mice. J Lipid Res 2005; 46: 2091–2101
   PubMed Web of Science ®Google Scholar
• Kisilevsky R, Tam S P, Ancsin J B. The anti-atherogenic potential of serum amyloid A (SAA) peptides. Curr Opin Invest Drugs in press
   Google Scholar
• Macchia T, Mancinelli R, Barbini D A, Taggi F, Avico U, Cantafora A. Determination of membrane cholesterol in normal and pathological red blood cells. Clin Chim Acta 1991; 199: 59–67
   PubMed Web of Science ®Google Scholar
• Kisilevsky R, Narindrasorasak S, Tape C, Tan R, Boudreau L. During AA amyloidogenesis is proteolytic attack on serum amyloid A: a pre- or post-fibrillogenic event?. Amyloid 1994; 1: 174–183
   Web of Science ®Google Scholar
• Axelrad M A, Kisilevsky R, Willmer J, Chen S J, Skinner M. Further characterization of amyloid enhancing factor. Lab Invest 1982; 47: 139–146
   PubMed Web of Science ®Google Scholar
• Allain C C, Poon L S, Chan C SG, Richmond W, Fu P C. Enzymatic determination of total serum cholesterol. Clin Chem 1974; 20: 470–475
   PubMed Web of Science ®Google Scholar
• de Oliveira R M, Sipe J D, de Beer F C, Loose L D, Bartle L M, Cecil D, Franzblau C. Rapid, sensitive enzyme-linked immunosorbent assays (ELISA) for serum amyloid A (apoSAA) in human plasma and tissue culture fluids. Amyloid 1994; 1: 23–29
   Google Scholar
• Ancsin J B, Kisilevsky R. The heparin/heparan sulfate-binding site on apo-serum amyloid A: implications for the therapeutic intervention of amyloidosis. J Biol Chem 1999; 274: 7172–7181
   PubMed Web of Science ®Google Scholar
• Lowry O H, Rosebrough N J, Farr A L, Randall R J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Sadler T E, Alexander P. Trapping and destruction of blood-borne syngeneic leukemia cell in lung, liver and spleen of normal and leukemic rats. Br J Cancer 1976; 33: 512–520
   PubMedGoogle Scholar
• Heyns A D, Lotter M G, Kotze H F, Wessels P, Pieters H, Badenhorst P N. Kinetics, distribution, and sites of destruction of indium-111 oxine labelled red cells in haemolytic anaemia. J Clin Pathol 1985; 38: 128–132
   PubMedGoogle Scholar
• Lindhorst E, Young D, Bagshaw W, Hyland M, Kisilevsky R. Acute inflammation, acute phase serum amyloid A and cholesterol metabolism in the mouse. Biochim Biophys Acta 1997; 1339: 143–154
   PubMed Web of Science ®Google Scholar
• Lowell C A, Stearman R S, Morrow J F. Transcriptional regulation of serum amyloid A gene expression. J Biol Chem 1986; 261: 8453–8461
   PubMed Web of Science ®Google Scholar
• Morrow J F, Stearman R S, Peltzman C G, Potter D A. Induction of hepatic synthesis of serum amyloid A protein and actin. Proc Natl Acad Sci USA 1981; 78: 4718–4722
   PubMed Web of Science ®Google Scholar
• Feingold K R, Hardardottir I, Memon R, Krul E JT, Moser A H, Taylor J M, Grunfeld C. Effect of endotoxin on cholesterol biosynthesis and distribution in serum lipoproteins in Syrian hamsters. J Lipid Res 1993; 34: 2147–2158
   PubMedGoogle Scholar
• Hardardottir I, Kunitake S T, Moser A H, Doerrler W T, Rapp J H, Grunfeld C, Feingold K R. Endotoxin and cytokines increase hepatic messenger RNA levels and serum concentrations of apolipoprotein J (clusterin) in Syrian hamsters. J Clin Invest 1994; 94: 1304–1309
   PubMedGoogle Scholar
• Memon R A, Grunfeld C, Moser A H, Feingold K R. Tumor necrosis factor mediates the effects of endotoxin on cholesterol and triglyceride metabolism in mice. Endocrinology 1993; 132: 2246–2253
   PubMed Web of Science ®Google Scholar
• Aster J C. Diseases of white blood cells, lymph nodes, spleen and thymus. Robbins and Cotran: Pathologic Basis of Disease7th ed, V Kumar, A K Abbas, N Fausto. Elsevier-Saunders, Philadelphia 2005; 661–709
   Google Scholar
• Uguccioni M, Meliconi R, Lalli E, Nesci S, Delfini C, Lucarelli G, Gasbarrini G, Facchini A. Serum amyloid-A protein concentration in bone marrow transplantation for beta-thalassaemia. J Clin Pathol 1992; 45: 348–351
   PubMed Web of Science ®Google Scholar
• Westerman M P, Pierce L E, Jensen W N. Erythocyte and plasma lipids in sickle cell anemia. Blood 1964; 23: 200–205
   PubMedGoogle Scholar
• Akohoue S A, Shankar S, Milne G I, Morrow J, Chen K Y, Ajayi W U, Buchowski M S. Energy expenditure, inflammation, and oxidative stress in steady-state adolescents with sickle cell anemia. Pediatr Res 2007; 61: 233–238
   PubMed Web of Science ®Google Scholar
• Hibbert J M, Hsu L L, Bhathena S J, Irune I, Sarfo B, Creary M S, Gee B E, Mohamed A I, Buchanan I D, Al-Mahmoud A, Stiles J K. Proinflammatory cytokines and the hypermetabolism of children with sickle cell disease. Exp Biol Med 2005; 230: 68–74
   PubMed Web of Science ®Google Scholar
• Belcher J D, Bryant C J, Nguyen J, Bowlin P R, Kiebik M C, Bischof J C, Hebbel R P, Vercellotti G M. Transgenic sickle mice have vascular inflammation. Blood 2003; 101: 3953–3959
   PubMed Web of Science ®Google Scholar
• Bourantas K L, Dalekos G N, Makis A, Chaidos A, Tsiara S, Mavridis A. Acute phase proteins and interleukins in steady state sickle cell disease. Eur J Haematol 1998; 61: 49–54
   PubMed Web of Science ®Google Scholar
• Hedo C C, Aken'ova Y A, Okapala I E, Durojaiye A O, Salimonu L S. Acute phase reactants and severity of homozygous sickle cell disease. J Intern Med 1993; 233: 467–470
   PubMed Web of Science ®Google Scholar
• Rahimi Z, Merat A, Haghshenass M, Madani H, Rezaei M, Nagel R L. Plasma lipids in Iranians with sickle cell disease: hypocholesterolemia in sickle cell anemia and increase of HDL-cholesterol in sickle cell trait. Clin Chim Acta 2006; 365: 217–220
   PubMed Web of Science ®Google Scholar
• Shores J, Peterson J, VanderJagt D, Glew R H. Reduced cholesterol levels in African-American adults with sickle cell disease. J Natl Med Assoc 2003; 95: 813–817
   PubMed Web of Science ®Google Scholar
• Monnet D, Kane F, Konan-Waidhet D, Diafouka F, Sangare A, Yapo A E. Lipid, apolipoprotein AI and B levels in Ivorian patients with sickle cell anaemia. Ann Biol Clin Paris 1996; 54: 285–288
   PubMedGoogle Scholar
• el-Hazmi M A, Warsy A S, al-Swailem A, al-Swailem A, Bahakim H. Red cell genetic disorders and plasma lipids. J Trop Med 1995; 41: 202–205
   Google Scholar
• el-Hazmi M A, Jabbar F A, Warsy A S. Cholesterol and triglyceride level in patients with sickle cell anaemia. Scand J Clin Lab Invest 1987; 47: 351–354
   PubMed Web of Science ®Google Scholar
• Akinyanju P A, Akinyanju C O. Plasma and red cell lipids in sickle cell disease. Ann Clin Lab Sci 1976; 6: 521–524
   PubMedGoogle Scholar
• Westerman M P. Hypocholesterolaemia and anaemia. Br J Haematol 1975; 31: 87–94
   PubMed Web of Science ®Google Scholar
• Goldfarb A W, Rachmilewitz E A, Eisenberg S. Abnormal low and high density lipoproteins in homozygous beta-thalassemia. Br J Haematol 1991; 79: 481–486
   PubMed Web of Science ®Google Scholar
• Fatouros M, Bourantas K, Bairaktari E, Elisaf M, Tsolas O, Cassioumis D. Role of the spleen in lipid metabolism. Br J Surg 1995; 82: 1675–1677
   PubMed Web of Science ®Google Scholar